Skip to main content

J&J completes tender offer of Cougar Biotechnology


NEW BRUNSWICK, N.J. Drug maker Johnson & Johnson has completed its tender offer for a Los Angeles-based biotech company.

J&J announced last week that its tender offer for Cougar Biotechnology expired at midnight Thursday, with 84.4% of the outstanding shares of Cougar’s common stock validly tendered and not withdrawn.

The company said that it would also offer to acquire all remaining shares of Cougar by this Thursday.

This ad will auto-close in 10 seconds